–§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞ : Impact Factor & More
eISSN: 2588-0527pISSN: 2686-8849
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
–§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞ Journal Specifications
| Overview | |
| Publisher | Izdatelstvo OKI |
| Language | Russian |
| Publication Time | 4 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞ ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞
Clinical pharmacologists are ambassadors of pharmacogenetics: highlights from the ClinPharm-Expert 2026 congress
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
CYP2A6 polymorphisms as predictors of IVF efficacy: the role of local estrogen metabolism under hyperestrogenic conditions
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Pharmacogenetic aspects of drug interactions in stroke patients (using the CYP2C9 gene as an example)
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Genetic markers of the effectiveness of anti-VEGF therapy in age-related macular degeneration
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Pharmacogenetic approach to prescribing medications in cardiac surgery patients at high risk of complications
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Omics biomarkers of antipsychotic efficacy and safety: focus on lurasidone
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Clinical pharmacologists are ambassadors of pharmacogenetics: highlights from the ClinPharm-Expert 2026 congress
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
CYP2A6 polymorphisms as predictors of IVF efficacy: the role of local estrogen metabolism under hyperestrogenic conditions
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Pharmacogenetic aspects of drug interactions in stroke patients (using the CYP2C9 gene as an example)
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Genetic markers of the effectiveness of anti-VEGF therapy in age-related macular degeneration
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Pharmacogenetic approach to prescribing medications in cardiac surgery patients at high risk of complications
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
Omics biomarkers of antipsychotic efficacy and safety: focus on lurasidone
- 15 Aug 2026
- Pharmacogenetics and Pharmacogenomics
FAQs on –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞
How many articles did –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞ publish last year? 
What is the eISSN & pISSN for –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞?
Who is the publisher of –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∞ –∏ –§–∞—Ä–º–∞–∫–æ–≥–µ–Ω–æ–º–∏–∫–∞?
